US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
AMEX
YM Biosciences Ordinary Shares (Canada) (YMI)
YM Biosciences Ordinary Shares (Canada) (YMI) ニュース

YMI

YM Biosciences (YMI)

YM Biosciences Ordinary Shares (Canada)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:YMI

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2010/11/09	07 : 08	PR Newswire (US)	YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/11/09	03 : 03	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/11/09	01 : 53	PR Newswire (US)	YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/26	05 : 49	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/26	01 : 40	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/15	00 : 47	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/14	20 : 00	PR Newswire (US)	YM BIOSCIENCES APPOINTS DR. NICK GLOVER AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES ANNUAL MEETING	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/02	02 : 26	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/10/01	20 : 30	PR Newswire (US)	YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/30	00 : 57	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/29	20 : 30	PR Newswire (US)	YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/25	01 : 30	Edgar (US Regulatory)	Annual Report (foreign private issuer) (40-F)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/24	19 : 03	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/24	06 : 00	PR Newswire (US)	YM BioSciences reports fiscal year end 2010 operational and financial results	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/09	01 : 34	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/09/08	20 : 30	PR Newswire (US)	YM BioSciences announces positive results from CYT997 Phase I study published in British Journal of Cancer	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/08/21	06 : 05	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/08/11	02 : 02	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/08/10	20 : 30	PR Newswire (US)	YM BioSciences granted Orphan Drug Designation for CYT387	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/08/06	02 : 14	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/08/05	20 : 00	PR Newswire (US)	YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/06/04	19 : 02	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/06/04	06 : 00	PR Newswire (US)	YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/06/04	02 : 47	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/06/04	01 : 58	Edgar (US Regulatory)	Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/06/03	20 : 30	PR Newswire (US)	YM BioSciences raises US$3.2 million in support of JAK 1/2 program	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/05/28	00 : 10	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/05/27	20 : 30	PR Newswire (US)	YM BioSciences enrolls first US patient in Phase II randomized, double-blind brain metastases trial for nimotuzumab	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/05/22	01 : 15	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2010/05/21	20 : 30	PR Newswire (US)	YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)

Showing the most relevant articles for your search:AMEX:YMI

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 次へ >>

Deutsche Telekom (QX)

American Express

Bank of America

US Dollar vs Yen

JP Morgan Chase

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約